ArticleIJU case reports2026

A Rare Case of Suspected Immune-Related Encephalopathy Following Pembrolizumab Plus Lenvatinib Therapy for Renal Cell Carcinoma.

Yuina Nagao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.